David Pérez Silguero

Dr. David Pérez Silguero

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
MPMiguel Angel Perez-Silguero
Miguel Angel Perez-Silguero
DSDavid Pérez Silguero
David Pérez Silguero
ARAmado Rivero-Santana
Amado Rivero-Santana
MBMaria Inmaculada Bernal-Blasco
Maria Inmaculada Bernal-Blasco
PEPablo Encinas-Pisa
Pablo Encinas-Pisa
Purpose: To assess the effectiveness of a combination of intense pulsed light and low-level light therapy (IPL/LLLT) for the treatment of dry eye. Study Design: Retrospective before-after single-center clinical study. Materials and Methods: Patients diagnosed with dry eye, refractory to conventional treatment, underwent four sessions of combined IPL/LLLT over 3 months. The Ocular Surface Disease Index (OSDI) questionnaire, non-invasive breakup time (NIBUT), tear film osmolarity and meniscus height were measured 6 months before intervention, at baseline, post-intervention (3 months), 9 and 15 months. Results: NIBUT, osmolarity and meniscus height significantly worsened during the 6 months before treatment, whereas symptoms did not change. OSDI scores significantly improved at post-intervention (MD = − 44.0, 95% CI − 38.1, − 50.0), and then increased again until the at last follow-up, but still significantly different from baseline (MD = − 30.0, 95% CI − 23.4, − 36.8). The three clinical signs showed a similar pattern, with one-year improvements of 3.6 seconds for the NIBUT (95% CI 3.1, 4.2, p < 0.001), 28 mOsm/L for osmolarity (95% CI 23.6, 32.4, p < 0.001) and 0.03 mm for meniscus height (95% CI 0.02, 0.04, p < 0.001). No adverse effects were observed. Conclusion: IPL/LLLT is safe and produces an important reduction in symptoms and signs of dry eye disease, still relevant one year after the end of treatment in a sample with high symptoms’ severity. Therefore, it represents a promising treatment option for patients who do not improve with conventional treatment. Randomized trials are needed to determine the added benefit provided by LLLT.

1 October 2020 in Archivos de la Sociedad Española de Oftalmología
Verified
Journal Article
Closed access
DSDavid Pérez Silguero
David Pérez Silguero
MSM.á. Pérez Silguero
M.á. Pérez Silguero
SJS. Pérez-Silguero Jiménez
S. Pérez-Silguero Jiménez
PPP. Encinas Pisa
P. Encinas Pisa

1 April 2020 in Archivos de la Sociedad Española de Oftalmología
Verified
Journal Article
Closed access
DSDavid Pérez Silguero
David Pérez Silguero
MSMiguel Ángel Pérez Silguero
Miguel Ángel Pérez Silguero
SJSara Pérez-Silguero Jiménez
Sara Pérez-Silguero Jiménez
PPPablo Encinas Pisa
Pablo Encinas Pisa

1 January 2014 in Archivos de la Sociedad Española de Oftalmología
Verified
Journal Article
Closed access
DSDavid Pérez Silguero
David Pérez Silguero
ADA. Díaz-Ginory
A. Díaz-Ginory
CSC. Santana-Rodríguez
C. Santana-Rodríguez
MPM.A. Pérez-Silguero
M.A. Pérez-Silguero

25 May 2026 in Medicina
Verified
Journal Article
Open access
PDF file
DSDavid Pérez Silguero
David Pérez Silguero
MPMiguel Ángel Pérez-Silguero
Miguel Ángel Pérez-Silguero
PEPablo Encinas-Pisa
Pablo Encinas-Pisa
MÁMaría Mayoral Álvarez
María Mayoral Álvarez
AGAlonso Verbo Gil
Alonso Verbo Gil
IBInmaculada Bernal-Blasco
Inmaculada Bernal-Blasco
Background and Objectives: To evaluate two-year functional, anatomical, and patient-reported outcomes after bilateral implantation of a diffractive implantable phakic contact lens (IPCL) for presbyopia correction in myopic patients within a high–solar-radiation Atlantic island environment. Methods: This retrospective observational study included 11 presbyopic myopic patients aged 40–50 years (22 eyes) who underwent bilateral diffractive IPCL implantation and completed a 2-year follow-up. Monocular defocus curves were recorded from +3.0 to −5.0 D and converted to logMAR. Functional visual range and area under the defocus curve (AUC) were calculated. Anatomical stability was assessed by central vault, pupil diameter, and crystalline lens rise measurements. Safety evaluation included slit-lamp examination for crystalline lens transparency and corneal integrity. Patient-reported outcomes were measured using the Quality of Vision (QoV) and Catquest-9SF questionnaires. Environmental parameters during implantation and follow-up were characterized using regional meteorological data. Results: Mean visual acuity remained ≤0.14 logMAR up to −2.5 D of defocus, with functional vision (≤0.2 logMAR) extending to approximately −3.0 D in about half of the eyes. Median vault at 2 years was 546 µm (IQR 361.5–667.3 µm). No cases of clinically significant cataract or corneal compromise were observed. QoV scores were low (1.41 ± 0.43) and Catquest-9SF scores high (3.70 ± 0.18), with no strong correlations between subjective and anatomical metrics. Visual performance remained stable within a consistent high-solar-radiation and atmospheric light-scattering environment. Conclusions: Diffractive IPCL implantation was associated with stable anatomical positioning, sustained functional visual performance across distances, and favorable patient-reported outcomes at 2 years. Within a consistent real-world environmental context, these findings provide a descriptive framework for understanding diffractive IPCL performance, while larger prospective studies are warranted.

1 August 2021 in Archivos de la Sociedad Española de Oftalmología (English Edition)
Verified
Journal Article
Closed access
DSDavid Pérez Silguero
David Pérez Silguero
MSM.á. Pérez Silguero
M.á. Pérez Silguero
SJS. Pérez-Silguero Jiménez
S. Pérez-Silguero Jiménez
PPP. Encinas Pisa
P. Encinas Pisa